Identification and Characterization of the RNA Modifying Factors PUS7 and WTAP as Key Components for the Control of

Tim Hohmann1, Urszula Hohmann1, Faramarz Dehghani1

  • 1Department of Anatomy and Cell Biology, Medical Faculty, Martin Luther University Halle-Wittenberg, Grosse Steinstrasse 52, 06108 Halle (Saale), Germany.

Insights

RNA modifications like pseudouridinylation and m6A methylation are crucial in cancer. This study links pseudouridine synthase 7 (PUS7) and WT1-associated protein (WTAP) to renal cell carcinoma (RCC) progression and survival.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • RNA modifications are increasingly recognized for their role in cancer development.
  • Key modifications include pseudouridinylation and N6-methyladenosine (m6A) methylation.
  • These modifications impact essential cellular processes like proliferation and survival.

Purpose of the Study:

  • To investigate the role of RNA-modifying factors pseudouridine synthase 7 (PUS7) and WT1-associated protein (WTAP) in renal cell carcinoma (RCC).
  • To correlate PUS7 and WTAP expression with tumor markers, immune checkpoints, and patient survival.
  • To identify novel mRNA targets regulated by PUS7 and WTAP in RCC.

Main Methods:

  • Comparative analysis of RNA-modifying factors PUS7 and WTAP in human RCC tumor data.
  • Statistical correlation analysis with proliferation markers (CXCR4, TP53, PTEN, NRAS) and immune checkpoints (HLA-G, LGALS9).
  • Identification of PUS7 and WTAP target mRNAs using bioinformatics approaches.

Main Results:

  • PUS7 and WTAP expression significantly correlated with proliferation and prognosis markers in RCC.
  • Both factors showed a significant association with overall survival in RCC patients.
  • Identified target mRNAs involved in mitosis, cell cycle, cell division, and the WNT pathway.

Conclusions:

  • PUS7 and WTAP are important RNA-modifying factors implicated in RCC pathogenesis.
  • These factors influence key cellular processes and patient outcomes in renal cell carcinoma.
  • Targeting PUS7 and WTAP may offer novel therapeutic strategies for RCC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K